ADSCs can also have their therapeutic potential in liver fibrosis enhanced by preconditioning with cytokines [91], polyphenols [138], 3D culture [98], transfection with plasmids (FGF-2) [145], HGF, and miRNA [110]. This evidence concerns the gene FGF2 and Hepatic fibrosis.